ARTIKEL: Clinical Pharmacokinetics and Pharmacodynamics of Albiglutide

​Dr. Andreas Brønden provides a meticulous review of the GLP-1 receptor agonist albiglutide’s PK and PD and conclude that “Compared with other GLP-1RAs, albiglutide seems clinically non-inferior in terms of effects on glycaemia, better in terms of gastrointestinal adverse events, but inferior in terms of weight loss”. Good job, Dr. Brønden!

​Læs hele artiklen i tidsskriftet: 'Clinical Pharmacokinetics'.

Brønden, A., Knop, F.K. & Christensen, M. Clin Pharmacokinet (2017). doi:10.1007/s40262-016-0499-8 (åbner i nyt vindue)